ArticleFrontiers in nutrition2025
Dietary vitamin B9 intake linked to drug-resistant epilepsy risk in western Chinese adults: exploring underlying metabolomic mechanisms.
Article in Frontiers in nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Approximately 30% of epilepsy patients develop drug-resistant epilepsy (DRE), underscoring the need for adjunctive therapies. While dietary interventions like the ketogenic diet show promise, evidence for specific micronutrients, particularly regarding differences between DRE and non-drug-resistant epilepsy (NRE), remains scarce. This study investigated B-vitamin intake and plasma metabolomic profiles in NRE versus DRE patients. Methods: We established a cohort of 330 adults with epilepsy (165 NRE, 165 DRE) from western China. Dietary intake of vitamins B1, B6, B9, and B12 was assessed. Multivariate logistic regression and restricted cubic splines (RCS) analyzed associations between vitamin intake and DRE risk. Stratified analyses evaluated consistency across subgroups. Untargeted metabolomics was performed on a subset of patients to identify differential metabolites and pathways. Results: In the fully adjusted model, only dietary vitamin B9 (folate) intake was significantly and inversely associated with DRE risk (OR: 0.78 per 100 μg, 95% CI: 0.64-0.94; Conclusion: This study identifies lower dietary vitamin B9 intake as an independent risk factor for DRE in a Chinese adult cohort, with each 100 μg increase conferring a 22% reduction in risk. The metabolomic findings provide potential mechanistic insights, linking folate intake to dysregulated stress hormone, inflammatory, and one-carbon metabolism pathways in DRE. These results highlight the potential of nutritional assessment and intervention in the management of drug-resistant epilepsy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.